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Abstract
Background: Previously, we documented the presence of ovulation-inducing factor (OIF) in the seminal plasma of 
llamas and alpacas. The purpose of the study was to define the biochemical characteristics of the molecule(s) in 
seminal plasma responsible for inducing ovulation.
Methods: In Experiment 1, llama seminal plasma was centrifuged using filtration devices with nominal molecular mass 
cut-offs of 30, 10 and 5 kDa. Female llamas (n = 9 per group) were treated i.m. with whole seminal plasma (positive 
control), phosphate-buffered saline (negative control), or the fraction of seminal plasma equal or higher than 30 kDa, 
10 to 30 kDa, 5 to 10 kDa, or < 5 kDa. In Experiment 2, female llamas (n = 7 per group) were given an i.m. dose of 
seminal plasma treated previously by: 1) enzymatic digestion with proteinase-K, 2) incubation with charcoal-dextran, 3) 
heating to 65°C, or 4) untreated (control). In Experiment 3, female llamas (n = 10 per group) were given an i.m. dose of 
pronase-treated or non-treated (control) seminal plasma. In all experiments, llamas were examined by transrectal 
ultrasonography to detect ovulation and CL formation. Ovulation rate was compared among groups by Fisher's exact 
test and follicle and CL diameters were compared among groups by analyses of variance or student's t-tests.
Results: In Experiment 1, all llamas in the equal or higher than 30 kDa and positive control groups ovulated (9/9 in 
each), but none ovulated in the other groups (P < 0.001). In Experiment 2, ovulations were detected in all llamas in each 
treatment group; i.e., respective treatments of seminal plasma failed to inactivate the ovulation-inducing factor. In 
Experiment 3, ovulations were detected in 0/10 llamas given pronase-treated seminal plasma and in 9/10 controls (P < 
0.01).
Conclusions: We conclude that ovulation-inducing factor (OIF) in llama seminal plasma is a protein molecule that is 
resistant to heat and enzymatic digestion with proteinase K, and has a molecular mass of approximately equal or 
higher than 30 kDa.
Background
In his monograph of The Biochemistry of Semen nearly 50
years ago, Thaddeus Mann summarized the natural prop-
erties of seminal plasma as a vehicle for sperm transport,
a controller of sperm motility and capacitation, and as a
stimulant of uterine contractility [1]. In light of recent
studies, however, we now know that the role of seminal
plasma also includes effects on ovarian function in the
inseminated female. Intramuscular or intrauterine depo-
sition of llama or alpaca seminal plasma induced ovula-
tion in females of both species [2] - species classified as
reflex or induced ovulators [3,4]. Results support the
hypothesis that the ovulation-inducing factor (OIF) in
seminal plasma effects ovulation via a systemic rather
than a local route since 1) intramuscular administration
of seminal plasma in female llamas and alpacas resulted
in a surge in circulating concentrations of LH within 15
minutes of treatment [2], 2) disruption of the endometrial
mucosa by curettage facilitated absorption of OIF and
increased the ovulatory effect of seminal plasma given by
intrauterine infusion, and 3) ovulation was not associated
with physical stimulation of the genital tract [5].
Results of studies in South American camelids are con-
sistent with early studies in Bactrian camels in which
ovulation was induced by intravaginal semen deposition
without any physical contact with the male [6]. Authors
of studies on human seminal plasma reported the pres-
ence of molecules that immuno-reacted with GnRH anti-
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bodies [7,8], but it is unknown if these immuno-reactive
molecules can induce ovulation in humans. Based on LH
secretion from primary cultures of rat pituitary cells [9],
the putative ovulation-inducing factor in alpaca seminal
plasma had GnRH-like activity but was not GnRH since
its biological activity was not suppressed when anti-
GnRH antibodies were added to the culture medium.
The findings of studies done in camelids have implica-
tions that extend beyond camelid species. Ovulation-
inducing factor has been detected in the seminal plasma
of species that are not classified as induced ovulators; i.e.,
bull [10], stallion and boar [11]. The role of OIF in cattle
has not been determined, but the preovulatory LH surge
was advanced in cows when mating was done during the
first 6-8 hours of behavioral estrus versus later [12]. As
well, intrauterine deposition of boar seminal plasma
accelerated ovulation in gilts [13]. Whether these factors
are related to the ovulatory mechanism in humans or
other species, and whether these factors are related to
those of camelids, remains unknown.
To date, the biochemical composition of OIF, as a single
or complex of elements, has not been identified. The pur-
pose of this study was to provide preliminary biochemical
characterization of the molecule(s) present in the seminal
plasma of llamas responsible for inducing ovulation in
this species. By attempting to inactivate or exclude the
bioactive fraction of seminal plasma, the specific objec-
tives were to 1) determine the approximate molecular
mass cut-off fractions that are associated with a loss of
bioactivity (Experiment 1), 2) determine the bioactivity of
llama seminal plasma after enzymatic digestion with pro-
teinase K, filtration with charcoal dextran, or heat treat-
ment (Experiment 2), and 3) determine the effects of
more aggressive enzymatic digestion with pronase E on
the bioactivity of OIF (Experiment 3).
Methods
Experiment 1 - molecular mass cut-off
The experiment was conducted during February to
March at the Quimsachata Research Station in the
Department of Puno, Peru (15°S, 71°W, and 4,500 m
above sea level). Semen was collected from 3 llamas using
a phantom mount fitted with an artificial vagina [2]. Ejac-
ulates were diluted 1:1 (v/v) with phosphate buffered
saline (PBS, Gibco, Grand Island, N.Y., USA) and centri-
fuged for 30 minutes at 1500 × g. The supernatant was
decanted from the spermatozoa and a drop was evaluated
by microscopy to confirm the absence of cells. If sperma-
tozoa were detected, the sample was centrifuged again in
like manner. Sperm-free seminal plasma was stored at -
70°C. At the time of use, the stored seminal plasma was
thawed and ejaculates were pooled within and among
males. A 15 ml volume of pooled seminal plasma was
fractionated in a sequential manner using centrifugal fil-
ter devices with nominal molecular mass limits of 30, 10,
and 5 kDa (Amicon Ultra-15, Millipore Corporation,
Bedford, MA, USA). The 15 ml sample was initially
loaded into a 20 ml filter device with a molecular mass
cut off of 30 kDa and centrifuged at 2500 g for 45 minutes
at 4°C. After centrifugation, the retained volume (20 ul)
was re-suspended to the original volume of 15 ml with
PBS supplemented with 50 μg/ml of kanamycin (Sigma
Chemical Co., St Louis, MO, USA) and stored at -20°C as
the ≥ 30 kDa fraction of seminal plasma. The portion of
seminal plasma that passed through the 30 kDa filter was
subsequently loaded into a filter device with a molecular
mass cut off of 10 kDa and was centrifuged in like-man-
ner. Again, the retained volume after centrifugation was
re-suspended to the original volume of the sample (15 ml)
and stored as the 10-30 kDa fraction of seminal plasma.
The remaining filtrate was loaded into a filter device with
a molecular mass cut off of 5 kDa, and centrifuged as
described. Both the retained portion as well as the filtrate
were re-suspended to the original sample volume (15 ml),
as described, and stored as the 5-10 kDa and < 5 kDA
fractions, respectively. Thus, the process yielded four
fractions of seminal plasma based on approximate molec-
ular mass (i.e., ≥ 30 kDa, 10-30 kDa, 5-10 kDa, and < 5
kDa).
Mature non-lactating female llamas (n = 60), ≥ 4 years
of age and weighing an average of 120 kg, were examined
daily by transrectal ultrasonography (Aloka SSD 500,
Tokyo, Japan) using a 7.5 MHz linear-array transducer.
Llamas were selected (n = 54) when a growing follicle of ≥
8 mm in diameter was detected (i.e, capable of ovulating)
[14], and then assigned randomly to 6 groups (n = 9 per
group). In the respective groups, llamas were given an
intramuscular dose of 1.5 ml of whole seminal plasma
(positive control), or the seminal plasma fraction ≥ 30 kD,
10 to 30 kD, 5 to 10 kD, or ≤ 5 kD, or PBS (negative con-
trol). Llamas were examined daily by transrectal ultra-
sonography until Day 2 (Day 0 = treatment) to detect
ovulation, and again on Day 8 to detect the presence of a
corpus luteum (CL). Ovulation was defined as the sudden
disappearance of a large follicle (≥ 8 mm) that was
detected during the previous examination, and was con-
firmed by subsequent detection of a CL [14,15].
Experiment 2 - treatment with proteinase K, charcoal, or 
heat
The experiment was conducted from October to Novem-
ber at the University of Saskatchewan, Canada (52° N,
106° W and 500 m above sea level). Semen was collected
from 4 llamas by artificial vagina over a period of 2
months (22 ejaculates per animal), and was processed as
described above. A volume of 20 ml of seminal plasma
was prepared for each of 4 treatments: 1) enzymatic
digestion with proteinase-K (Promega Biosciences Inc,Ratto et al. Reproductive Biology and Endocrinology 2010, 8:44
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San Luis Obispo, California, USA), 2) incubation with
charcoal-dextran, 3) heating to 65°C, or 4) untreated
(control). Enzymatic digestion involved incubation with
500 μg/ml proteinase-K in a shaker water bath at 38°C for
1 hour. The enzymatic reaction was terminated by adding
phenylmethylsulfonyfluoride (PMSF, Sigma-Aldrich, St.
Louis, Missouri, USA) to a final concentration of 5 mM.
Samples were centrifuged at 1500 × g for 5 minutes and
the supernatant was aspirated and stored at -70°C. Incu-
bation with charcoal dextran (0.12 g/l: 12 g/l, Sigma-
Aldrich, St Louis, Missouri, USA) was done at 4°C over-
night, and charcoal was removed by centrifugation at
7500 × g for 15 minutes followed by filtration through a
series of 0.45-μm filters and finally through a 0.22-μm fil-
ter (Millipore Corporation, Bedford, MA, USA), and
stored at -70°C. Heat treatment involved incubation in
shaker water bath at 65°C for 10 minutes or 1 hour. The
sample was centrifuged at 1500 × g for 5 minutes, and the
supernatant was aspirated and stored at -70°C. For the
control group, seminal plasma was incubated in a shaker
water bath at 38°C for 1 hour without the presence of pro-
teinase-K, and PMSF was added to a final concentration
of 5 mM. The sample was centrifuged at 1500 × g for 5
minutes and the supernatant was aspirated and stored at
-70°C.
Mature non-lactating female llamas (n = 30), ≥ 4 years
of age and weighing 100-150 kg, were given 5 mg Armour
Standard LH (Lutropin-V, Bioniche Animal Health, Bel-
leville, ON, Canada) to synchronize follicular wave emer-
gence among animals [16]. Twelve days after LH
administration, llamas with a follicle ≥ 8 mm in diameter
were assigned randomly to 4 groups (n = 7 per group) and
given an intramuscular dose of 2 ml of seminal plasma
from the respective treatments. Llamas were examined
daily by transrectal ultrasonography until Day 2 (Day 0 =
treatment) to detect ovulation, and again on Day 8 to
detect the presence of a CL.
To examine the effects of treatment on seminal plasma
protein band profiles, samples from each treatment were
reduced, denatured, and separated by electrophoresis on
12% polyacrylamide gel (SDS-PAGE) based on the proto-
col of Laemmli [17]. Gels were stained with Coomassie
Blue R-250 (Sigma-Aldrich, St Louis, Missouri, USA).
Experiment 3 - treatment with pronase E
The experiment was conducted from May to June at the
University of Saskatchewan, Canada. Llama seminal
plasma (10 ml), collected as described in Experiment 2,
was incubated with pronase E (Sigma-Aldrich) at a final
concentration of 500 μg/ml, in a shaker water bath at
38°C for 1, 3, 6, 9, or 12 hours (2 ml seminal plasma sam-
ple/time). A sample from each incubation time was sub-
jected to protein separation by SDS-PAGE, as described
in Experiment 2. Based on the degree of enzymatic diges-
tion indicated by protein band patterns in the electropho-
resis gel, the 12-hour incubation period was selected for
the purposes of the following llama bioassay. A larger vol-
ume of llama seminal plasma (20 ml) was incubated with
pronase E for 12 hours, as described, and the reaction was
terminated by adding PMSF to a final concentration of 5
mM. A second volume of llama seminal plasma (20 ml)
was incubated without the presence of pronase E (con-
trol) in a shaker water bath at 38°C for 12 hours. Samples
were centrifuged at 1500 × g for 5 minutes, and the super-
natant was aspirated and stored at -70°C.
Mature non-lactating female llamas (n = 25), ≥ 4 years
of age and weighing 100-150 kg, were given 5 mg Armour
Standard LH (Lutropin-V) to synchronize follicular wave
emergence among animals, as described in Experiment 2.
Twelve days after LH administration, llamas with a folli-
cle ≥ 8 mm in diameter were assigned randomly to 2
groups (n = 10 per group) in which 2 ml of pronase-
treated seminal plasma or 2 ml of control seminal plasma
was given by intramuscular injection. Llamas were exam-
ined daily by transrectal ultrasonography until Day 2
(Day 0 = treatment) to detect ovulation, and again on Day
8 to detect the presence of a CL.
Statistical analyses
Ovulation rate was compared among groups by Fisher's
exact test in all experiments. The diameter of the domi-
nant follicle before treatment was compared among
groups by analysis of variance in Experiments 1 and 2,
and by student's t-test in Experiment 3. CL diameter was
compared among groups by student's t-test in the Experi-
ment 1 and by analysis of variance in Experiment 2.
Results
Experiment 1 - molecular mass cut-off
The diameter of the largest follicle at the time of treat-
ment did not differ (P = 0.9) among treatment groups and
ovulation was observed in only those treated with the ≥
30 kDa fraction or whole seminal plasma (Table 1). No
ovulations were detected in llamas given lower molecular
mass fractions of seminal plasma or in those given PBS
(negative control). The diameter of the CL on Day 8 (Day
0 = treatment) did not differ between groups treated with
the ≥ 30 kDa fraction or whole seminal plasma (Table 1).
Experiment 2 - treatment with proteinase K, charcoal, or 
heat
Ovulations were detected in all the llamas 7/7 (100%) in
each treatment group (Table 2). A CL was detected in all
females after treatment, and CL diameters did not differ
among groups. Gel electrophoresis of seminal plasma
treated with heat or charcoal dextran resulted in a similar
protein band pattern to that of untreated seminal plasma
(Fig. 1). However, treatment of seminal plasma with pro-
teinase K resulted in a markedly different protein band
pattern; proteins were rendered to less than 19.4 kDa.Ratto et al. Reproductive Biology and Endocrinology 2010, 8:44
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The prominent band with a molecular mass of ~30 kDa
was identified as proteinase K itself (Fig. 1-A, lanes 7 and
8).
Experiment 3 - treatment with pronase E
Ovulations were detected only in llamas given untreated
(control) seminal plasma (Table 3). A CL was detected in
all llamas that ovulated in the control group and in none
of the llamas given pronase E-treated seminal plasma.
Gel electrophoresis of seminal plasma treated with pro-
nase E resulted in a protein band pattern that was mark-
edly different from that of untreated seminal plasma (Fig.
1-B). The band pattern was similar among incubation
times (1, 3, 6, 9 and 12 hours), but the degree of enzy-
Table 1: Bioactivity of different molecular mass fractions of llama seminal plasma in female llamas (Experiment 1).
≥ 30 kDa
(n = 9)
10-30 kDa
(n = 9)
5-10 kDa
(n = 9)
< 5 kDa
(n = 9)
WSP
(n = 9)
PBS
(n = 9)
Follicle diameter*
(mm)
9.5 ± 0.7 9.3 ± 0.6 9.8 ± 0.7 10.0 ± 0.7 9.3 ± 0.5 11.3 ± 0.8
Ovulation
(%)
9/9a
(100%)
0/9b
(0%)
0/9b
(0%)
0/9b
(0%)
9/9a
(100%)
0/9b
(0%)
CL diameter on Day 8* 
(mm)
10.1 ± 0.5 ---- ---- ---- 10.8 ± 0.7 ----
Whole seminal plasma (WSP, positive control), phosphate buffered saline (PBS, negative control). Values expressed as mean ± SEM; Day 0 = 
treatment.
* No difference between groups (P = 0.9).
a, bProportions with different superscripts are different (P < 0.001).
Figure 1 Llama seminal plasma protein separation on SDS-PAGE after exposure to different treatments in Experiment 2 (A) and Experi-
ment 3 (B). Seminal plasma samples were reduced, denatured, and separated on 12% polyacrylamide gel and stained with Coomassie Blue R-250. A) 
Lane 1 was loaded with a molecular mass standard. The remaining lanes were loaded with 20 μg of seminal plasma (SP): Lane 2 - non-treated SP; Lane 
3 - SP kept at 38°C for 1 hour; Lane 4 - SP heated to 65°C for 10 min.; Lane 5 - SP heated to 65°C for 1 hour; Lane 6 -- SP treated with charcoal dextran 
at 4°C for 12 hours; Lane 7 -- SP treated with proteinase K (500 μg/ml) at 38°C for 1 hour; Lane 8 -- phosphate buffered saline (PBS) plus proteinase K 
(500 μg/ml) at 38°C for 1 hour; * Protein band represents proteinase K. B) Lane 1 was loaded with a molecular mass standard. The remaining lanes 
were loaded with 30 μg of seminal plasma: Lane 2 - non-treated seminal plasma (SP); Lane 3 - SP kept at 38°C for 12 hours; Lane 4 - phosphate buffered 
saline (PBS) plus pronase E (500 μg/ml) at 38°C for 1 hour; Lane 5, 6, 7, 8, 9 - Seminal plasma treated with pronase E (500 μg/ml) at 38°C for 1, 3, 6, 9 or 
12 hours, respectively. * Protein bands represent pronase E.Ratto et al. Reproductive Biology and Endocrinology 2010, 8:44
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matic digestion appeared more complete at the 12-hour
incubation period and was, therefore, selected for the
purposes of the llama bioassay. The consistent band pat-
tern at the ≤ 37.1 kDa marker in lanes containing pronase
E (Fig 1-B, lanes 4 to 9) identified the mixture of prote-
olytic enzymes constituting pronase E.
Discussion
The presence of a factor in seminal plasma responsible
for eliciting ovulation has been well documented in cam-
elids [2,6,18]. Camelids are species considered to be
induced-ovulators, but the ovulation-inducing factor has
also been detected in the seminal plasma of species con-
sidered to be spontaneous-ovulators [i.e., bull, stallion,
boar; [10,11,19]]. To date, the influence of specific com-
ponents of seminal plasma on ovarian function has not
been the subject of systematic examination. Several frac-
tions of Bactrian camel seminal plasma, eluted by ion-
exchange chromatography, have been proposed as bioac-
tive components [20,21], but interpretation of the results
is limited because of the lack of a validated bioassay to
quantitatively test the effects of various fractions. Fur-
thermore, the studies were not designed to examine non-
protein constituents of seminal plasma.
The experimental approach used in the present study
was aimed at identification through systematic attempts
to ablate the biological activity of OIF in seminal plasma.
To this end, OIF in llama seminal plasma was subjected to
molecular mass filtration to determine approximate size,
heat to determine if it is temperature labile, charcoal dex-
tran to determine if it is lipid soluble, and proteases to
determine if it is a protein. The bioactivity of fractions of
seminal plasma obtained after respective treatments was
tested using a validated llama ovulation bioassay [2].
Based on the results of Experiment 1, the molecular
mass of OIF present in llama seminal plasma is roughly ≥
30 kDa,  whi c h is c ons is t e n t  wi t h a  r eport  on Ba ct ria n
c a m e l s  i n  w h i c h  t h e  m o l e c u l e  w a s  s u g g e s t e d  t o  b e  a
folded complex of ≥ 50 kDa [20]. Initial attempts to inac-
tivate OIF in the present study (Experiment 2), however,
were unsuccessful and results document the robust
nature of OIF, in contrast to the labile nature of the factor
reported in Bactrian camels [20]. That is, the bioactivity
of OIF in seminal plasma was not altered by heat treat-
ment, charcoal dextran extraction, or enzymatic diges-
tion with proteinase K.
Given that the bioactive fraction was larger than a
rough cut-off of 30 kDa (Experiment 1), the inability to
inactivate OIF with proteinase K (Experiment 2) was
unexpected. Despite that seminal plasma proteins were
rendered to less than approximately 19 kDa with protei-
nase K, the bioactivity of seminal plasma remained intact.
Table 2: Bioactivity of llama seminal plasma after treatment with charcoal, proteinase K, or heat in female llamas 
(Experiment 2).
Seminal plasma treatment
Untreated
(n = 7)
Charcoal
(n = 7)
Proteinase K
(n = 7)
Heat 65°C
(n = 7)
Follicle diameter at 
treatment (mm)*
10.4 ± 0.9 10.8 ± 0.9 9.3 ± 0.2 9.0 ± 0.7
Ovulations* 7/7 7/7 7/7 7/7
CL diameter on Day 8 
(mm)*
10.5 ± 0.5 11.3 ± 0.7 11.7 ± 0.6 11.5 ± 0.8
Values expressed as mean ± SEM; Day 0 = treatment.
* No significant differences among groups
Table 3: Bioactivity of llama seminal plasma after treatment with pronase E in female llamas (Experiment 3).
Seminal plasma treatment
Untreated
(n = 10)
Pronase E
(n = 10)
Follicle diameter at treatment (mm) 9.7 ± 0.4a 9.0 ± 0.6a
Ovulations 9/10a 0/10b
Maximum CL diameter (mm) 10.8 ± 0.3 ----
Values expressed as mean ± SEM.
a, bWithin rows, values with different superscripts are different (P < 0.01).Ratto et al. Reproductive Biology and Endocrinology 2010, 8:44
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Because of this inconsistency and that the results of
Experiment 2 were inconclusive about the type of mole-
cule involved, a more aggressive protease (pronase E) was
chosen in Experiment 3 to determine if the molecule was
indeed a protein. Proteinase K is a serine endoprotease
[22] but pronase E is a mixture of endo- and exo-protei-
nases that hydrolyses practically all peptide linkages in
proteins and peptides [23]. Treatment of seminal plasma
with pronase resulted in more complete rendering of pro-
teins to < 15 kDa compared with proteinase K, and the
bioactivity of OIF was ablated. These results provide
rationale for the hypothesis that OIF is a protein with
more than one bioactive form based on molecular size.
Although not measured in this study, estrogen and
prostaglandin were considered unlikely candidates for
OIF because 1) their molecular mass (273 Da and 354 Da,
respectively) would have placed them in the ≤ 5 kDa frac-
tion of seminal plasma, yet no ovulation or CL develop-
ment was detected in females given this fraction
(Experiment 1), and 2) the bioactivity was not abolished
by steroid extraction with charcoal dextran (Experiment
2). The latter is consistent with the conclusion that estra-
diol does not play a role in eliciting the preovulatory LH
surge in induced ovulators [24].
Prostaglandin, present in boar seminal plasma or
s e c r e t e d  b y  t h e  e n d o m e t r i u m  i n  r e s p o n s e  t o  s e m i n a l
estrogens, has been implicated in the mechanism of ovu-
lation in gilts [25,26]; however, seminal plasma was given
by intrauterine infusion and it is not clear whether the
effect on ovulation was mediated directly at the level of
the ovary or if it was triggered by prostaglandin-induced
luteolysis followed by a preovulatory LH surge. In this
regard, seminal plasma was given intramuscularly in the
present study to minimize the potential confounding
effects of physical stimulation of the genital tract and
endogenous production of prostaglandin. Local prosta-
glandin, as an ovulation-inducing factor, is also inconsis-
tent with the collective results of three previous studies in
which 0/42 llamas and alpacas ovulated after intrauterine
deposition of phosphate buffered saline with or without
concomitant curettage of the endometrium [2,5]. Fur-
thermore, unlike prostaglandin, treatment with OIF was
associated with an immediate surge in circulating LH
concentrations; i.e., plasma LH concentrations in female
llamas increased within 15 minutes and peaked within 2
hours of intramuscular administration of llama seminal
plasma [2].
The hypothesis that OIF is a GnRH-like molecule is
inconsistent with the findings of a study in which the LH-
releasing effect of seminal plasma on rat pituitary cell cul-
ture was not suppressed when anti-GnRH antibodies
were added to the culture media [9]. Furthermore, by
direct comparison in vivo, OIF elicited a more sustained
LH surge than GnRH [2]. Lastly, GnRH is a decapeptide
with a molecular mass of 1.18 kDa - far below the bioac-
tive fraction identified in Experiment 1 - and unlike OIF,
GnRH is sensitive to proteolytic degradation (endopepti-
dases) within minutes [27].
We conclude that OIF in llama seminal plasma is a pro-
tein molecule with a molecular mass of roughly ≥ 30 kDa.
The factor is robust in that the bioactive component was
resistant to enzymatic digestion with proteinase K, and
incubation at 38°C for 12 h or at 65°C for 1 hour. Only
enzymatic digestion with pronase E abolished the ovula-
tion-inducing activity of llama seminal plasma.
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